Nymox Pharmaceutical (NYMXF) Return on Capital Employed [ROCE] (2018 - 2022)
Nymox Pharmaceutical (NYMXF) reported Return on Capital Employed [ROCE] of -2410.14% for Q4 2022, down 957.76 percentage points from -1452.38% a year earlier and down 1643.03 percentage points from the prior quarter.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Return on Capital Employed [ROCE] (2018 - 2022) Analysis & Trends
For FY2021, Nymox Pharmaceutical posted Return on Capital Employed [ROCE] of -1129.54%, down 732.39 percentage points from FY2020.
- Return on Capital Employed [ROCE] has a three-year change of -821.42 percentage points (FY2018 to FY2021).
- By year, Return on Capital Employed [ROCE] came in at -397.15% in FY2020 (-116.30 pp), -280.85% in FY2019 (+27.27 pp) and -308.12% in FY2018.
- The Q4 2022 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q2 2020.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last three quarters, with an average year-over-year change of +204.24 percentage points over the last seven quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2021 (a gain of 4974.18 percentage points); the low point was Q2 2020 (a drop of 5343.56 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.86% |
| 10 | Nymox Pharmaceutical | 3.84 Mn | 3.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -2,410.14% |
| Sep 30, 2022 | -767.11% |
| Jun 30, 2022 | -1,943.39% |
| Dec 31, 2021 | -1,452.38% |
| Sep 30, 2021 | -340.89% |
| Jun 30, 2021 | -522.25% |
| Mar 31, 2021 | -650.68% |
| Dec 31, 2020 | -380.92% |
| Sep 30, 2020 | -826.57% |
| Jun 30, 2020 | -5,496.43% |
| Mar 31, 2020 | -497.07% |
| Dec 31, 2019 | -300.28% |
| Sep 30, 2019 | -195.93% |
| Jun 30, 2019 | -152.87% |
| Mar 31, 2019 | -128.05% |
| Dec 31, 2018 | -198.77% |
API Access
Nymox Pharmaceutical Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();